Medical Xpress·3 min read·medium
In children with severe eczema, targeted treatment boosts growth
T
Trinity College Dublin
✦AI Summary
A study from Trinity College Dublin found that children with severe eczema often experience growth restriction. Treatment with the biologic drug dupilumab was shown to significantly improve height in these children compared to those who did not receive the medication.
Why it matters
This highlights the systemic impact of severe skin conditions on pediatric development and validates the use of targeted biologics for broader health benefits.
edited by Gaby Clark , reviewed by Andrew Zinin
sciencehealtheducation
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 95%
The report is based on peer-reviewed research and presents findings objectively.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in